Background: To mitigate mortality among critically ill COVID-19 patients, both during their Intensive Care Unit (ICU) stay and following ICU discharge, it is crucial to measure its frequency, identify predictors and to establish an appropriate post-ICU follow-up strategy. Methods: In this multicentre, prospective cohort study, we included 586 critically ill COVID-19 patients. Results: We observed an overall ICU mortality of 20.1% [95%CI: 17.1% to 23.6%] (118/586) and an overall hospital mortality of 25.4% [95%CI: 22.1% to 29.1%] (149/586). For ICU survivors, 30 days (early) post-ICU mortality was 5.3% [95%CI: 3.6% to 7.8%] (25/468) and one-year (late) post-ICU mortality was 7.9% [95%CI: 5.8% to 10.8%] (37/468). Pre-existing conditions/comorbidities were identified as the main independent predictors of mortality after ICU discharge: hypertension and heart failure were independent predictors of early mortality; and hypertension, chronic kidney disease, chronic obstructive pulmonary disease and cancer were independent predictors of late mortality. Conclusion: Early and late post-ICU mortality exhibited an initial surge (in the first 30 days post-ICU) followed by a subsequent decline over time. Close monitoring of critically ill COVID-19 post-ICU survivors, especially those with pre-existing conditions, is crucial to prevent adverse outcomes, reduce mortality and to establish an appropriate follow-up strategy.

Ventilator-associated pneumonia (VAP) remains one of the most common and challenging intensive care unit (ICU)-acquired infections, significantly contributing to mortality, morbidity, and healthcare costs. The diagnosis relies on quantitative analysis of a deep microbiological sample; a combination of clinical and radiological signs is commonly used to raise VAP suspicion in clinical practice. Traditional imaging methods such as chest radiography and computed tomography have limitations in critically ill patients under mechanical ventilation. Lung ultrasound (LUS) has emerged in the last years as a valuable tool in the assessment and monitoring of critically ill patients, including for diagnosis and management of VAP, due to its noninvasive bedside applicability and absence of radiation exposure. This last quality is of particular interest in the specific population of children and newborns, where radiation exposure should be further avoided. LUS allows for daily monitoring of lung aeration and provides a quantitative assessment through the LUS aeration score; an unexpected increase of LUS aeration score may raise the suspicion of superinfection. Key ultrasonographic findings, such as subpleural consolidations and consolidations with dynamic linear–arborescent air bronchogram, improve diagnostic specificity for VAP. Similarly to what happens with traditional radiology, the Ventilator-associated Pneumonia Lung Ultrasound Score (VPLUS) combines ultrasound signs with clinical parameters like purulent secretions to enhance diagnostic accuracy. Furthermore, LUS aeration score plays a crucial role in monitoring the response to treatment, enabling assessment of lung reaeration over time. It helps differentiate between treatment responders and nonresponders, guiding therapy adjustments and identifying complications. This review highlights the evolving role of LUS in the early diagnosis, monitoring, and treatment of VAP across various ICU settings, including its application in adult, pediatric, and neonatal care.

Acute hypoxemic respiratory failure (AHRF), particularly acute respiratory distress syndrome (ARDS), is characterized by marked heterogeneity in lung morphology and mechanics, requiring individualized mechanical ventilation strategies that balance adequate gas exchange with the prevention of ventilator-induced lung injury (VILI). Lung ultrasound (LUS) has become a cornerstone of critical care imaging, allowing differential diagnosis, quantitative assessment of lung aeration, phenotyping of ARDS morphology, and monitoring of disease evolution and complications. However, imaging alone does not provide direct guidance for optimizing ventilator settings. Some modern ventilators enable the rapid bedside acquisition of tidal pressure–volume (PV) loops, allowing tidal hysteresis to be measured and thereby providing complementary physiological information by identifying cyclic opening and closing of lung units and signs of overdistension. Emerging evidence supports the use of tidal hysteresis thresholds to identify insufficient positive end-expiratory pressure (PEEP) associated with tidal recruitment/derecruitment and to guide individualized PEEP titration during decremental PEEP trials. This review discusses the rationale and practical implementation of an integrated approach combining critical care ultrasound and PV loops throughout the management of mechanically ventilated patients with AHRF. We describe how ultrasound can support diagnosis, phenotyping, monitoring of lung aeration, and detection of ventilation-related complications, while PV loops provide a practical physiological framework for optimizing ventilator settings. This approach may provide a comprehensive, non-invasive, and repeatable bedside assessment of lung morphology, aeration, and respiratory mechanics, potentially facilitating personalized mechanical ventilation strategies aimed at reducing the risk of VILI and optimizing patient management.

After endovascular thrombectomy, contrast-enhanced CT was performed revealing a mass (18×10×25 mm) in the ascending aortic lumen, without evidence of aortic dissection, aneurysm or tortuosity of the aorta (figure 1). An infarction of the right kidney was also reported. Transoesophageal echocardiography (TEE) confirmed the presence of a pedunculated highly mobile echogenic mass attached to the anterior region of the aortic root, near the right coronary ostium, measuring >15 mm, suggestive of a thrombus. A 12 mm mobile echogenic mass in the anterior region of the left ventricular outflow tract (LVOT) was also identified, suggestive of a thrombus (online supplemental videos 1 and 2). Other findings included left ventricular inferior wall hypokinesia with normal left ventricular function, akinesia of the free wall and diaphragmatic wall of the right ventricle with severe right ventricular dysfunction and small patent foramen ovale with minimal shunt.